Clinical trial No longer in our active list Observational Ages Any age to 24 Hours

Analyzing bioimpedance in healthy newborns in China

Official title: Application of Bioimpedance Vector Analysis in Neonates

Run by Zhujiang Hospital · NCT06188377 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study looks at how body composition in healthy newborns in China is measured using a special tool to see if it differs from babies in other countries.

Quick facts

Study typeObservational
AgesAny age to 24 Hours
SexAll
Enrollment120 (estimated)
SponsorZhujiang Hospital
Academic / other
Locations1 site (Guangzhou, Guangdong)
Trial IDNCT06188377 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are healthy term neonates of both sexes within 24 hours of birth.

Probably not a fit

Patients who may not benefit from this study include those with diseases or conditions affecting body composition, such as heart failure or congenital anomalies.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate the distribution of bioimpedance vectors in healthy neonates within the first 24 hours of life in China. Using a NUTRILAB impedance analyzer, the study will collect demographic and health data from medical records and perform bioimpedance analysis on randomly selected newborns. Measurements will be taken under controlled conditions to ensure accuracy, and the results will be compared to similar data from other countries to assess any differences in bioimpedance distribution.

Why it matters

Potential benefit: If successful, this study could provide valuable insights into the normal bioimpedance characteristics of neonates, aiding in better health assessments.

How similar studies have gone: While this approach is observational and may have been used in other contexts, the specific application of bioimpedance vector analysis in healthy neonates is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Healthy term neonates of both sexes within 24 hours.
2. Neonates whose parents or guardians consent with the research.

Exclusion Criteria:

1. Infants with some disease and conditions that could interfere in the body composition (such as heart failure, blue light irradiation, sepsis, kidney injury, hepatic failure, transfusion) and newborns with congenital anomalies and/or genetic problems.
2. Neonates whose parents or guardians refuse to participate in the research.

Where it's running

  • Zhujiang Hospital of Southern Medical University
    Guangzhou, Guangdong, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.